Imagine if one plant did the work of all your prescriptions. 💊🌱 For many — it already does.

Something for the people, for the patients, for the passion behind the plant. We're bringing you something special. Coming soon... #4TP #4thepeople #4thepatient #4theplant

74.1% of suicides in England and Wales in 2022 were males. It's time to get better.

Heading into harvest over at Cannabudgrow 🌱

Patients with chronic pain average 15.3 GP visits a year (BJGP Open 2024). With that comes complex medication use. What if one plant could replace many? CINV is redefining patient care through high-quality, genetics-led CBPMs. #MedicalCannabis #ChronicPain #CINV

We are pleased to announce that Rory Bowen has been appointed to our Board of Directors. We look forward to the expertise and perspective Rory will bring as we continue to advance a trusted, international seed-to-heal model for medical flower and CBPMs. cinvcorp.com/cinv-appoints-…

Our work with CBG reflects controlled environments, trained teams and full plant traceability, helping protect the integrity of every CBPM produced. This shared commitment ensures consistent quality from cultivation to patient care 🌱

The industry is shifting from variable supply to pharmaceutical-grade cannabinoid medicine. CINV’s roadmap prioritises genetics, control, and consistency - building the foundations for true clinical reliability.  2026 will be a defining year.

Criggs Pharma delivers controlled, SAHPRA-licensed cultivation with predictable yields and strong clinical alignment.  A core partner in CINV’s active distribution phase.

Genetics shape consistency, terpene expression, and therapeutic potential.  Precision begins with the plant.

UK police have new national guidance to treat prescribed CBPM users as patients first, suspects second.  Clearer rules reduce stigma, improve patient experiences, and support the continued integration of regulated cannabinoid medicines into public systems.

🇫🇷 France has extended medical flower access again.  But the full framework is still unpublished. ✅ EU approved  ✅ Legal validated  🛑 Waiting on ministers Thousands protected — but new patients still locked out.  #MedicalFlower #France2026 #GlobalGreenReport #PatientAccess

Our work with CBG reflects controlled environments, trained teams and full plant traceability, helping protect the integrity of every CBPM produced. This shared commitment ensures consistent quality from cultivation to patient care 🌱